# C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.

> **NCT04935515** · NA · COMPLETED · sponsor: **Manimarane Arjunan, MD,DM (Cardiology)** · enrollment: 25 (actual)

## Conditions studied

- COVID -19

## Interventions

- **DRUG:** Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins
- **DRUG:** Oral low dose steroid
- **DRUG:** Intravenous Antibiotics with Low dose steroid.
- **DRUG:** Oral anti-coagulant

## Key facts

- **NCT ID:** NCT04935515
- **Lead sponsor:** Manimarane Arjunan, MD,DM (Cardiology)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-15
- **Primary completion:** 2021-05-09
- **Final completion:** 2021-06-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04935515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04935515, "C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04935515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*